Center for Medicine in the Public Interest

From Wikipedia, the free encyclopedia

The Center for Medicine in the Public Interest (CMPI) is a non-profit medical issues research group which is partially funded by the pharmaceutical industry[1]. Its agenda is research driven and deals with clinical outcomes and econometric studies that analyze the value of new medicines and genomic and molecular-based medical innovation. It claims to do this from the consumer's perspective.

CMPI is a 501(c)3 organization and as such is not permitted to devote a substantial part of its activity to lobbying, but its officers have written articles on various issues including price controls on pharmaceutical products in publicly funded healthcare schemes in the United States[2], and restrictions on advertising in the European Union[3]. The Economist Intelligence Unit has claimed that the organisation generally takes a pro-drug industry viewpoint[4].

Contents

[edit] Founders

CMPI was founded by Peter Pitts, former FDA Associate Commissioner for External Relations and Dr. Robert Goldberg, former fellow at the Manhattan Institute[5].

[edit] CMPI Senior Fellows

  • Marc Siegel, MD
  • Doug Badger
  • John F. P. Bridges
  • Jacob Arfwedson

[edit] Reports

CMPI has published studies on the value of new cancer drugs, the cost-effectiveness of certain Alzheimer's treatments, evidence-based medicine, drug counterfeiting[6] and healthcare terrorism.

[edit] External links

[edit] References

  1. ^ Herper, Matthew. "The Nissen Doctrine", Forbes, 2007-07-25. Retrieved on 2008-01-14. 
  2. ^ Goldberg, Robert. "HillaryCare Comes Back", The Weekly Standard, News America Incorporated, 2006-12-25. Retrieved on 2008-01-14. 
  3. ^ Pitts, Peter J.. "Power to the Patients", Wall Street Journal, 2006-04-12. Retrieved on 2008-01-14. 
  4. ^ "USA healthcare: FDA centenary prompts politicking", Economist Intelligence Unit, Economist Group, 2006-07-05. Retrieved on 2008-01-14. 
  5. ^ Jason Lee Miller (2008-08-01). Are Google Results Hazardous To Your Health?. WebProNews. iEntry, Inc.. Retrieved on 2008-01-14.
  6. ^ Laurie Sullivan (2006-06-13). Pharmaceuticals Slowly Adopting RFID To Protect Prescription Drug Supplies. Information Week. CMP Media LLC. Retrieved on 2008-01-14.